Human Trials Begin for Queensland’s Coronavirus Vaccine

Henrietta Strickland
July 13, 2020

"The research has been completed and it proved that the vaccine is safe", Yelena Smolyarchuk, the head of Sechenov University's clinical research center, told TASS of its trial.

Patna will start the human trail of coronavirus vaccine from Monday (July 13, 2020).

Till now, only the Bharat Biotech International Ltd and the Zydus Cadila pharmaceutical companies' indigenously developed vaccine prototypes have got an approval for the human trials from the Drugs Controller General of India.

"If everything goes according to plan, the vaccine will be ready for Thailand in the third or fourth quarter next year", Kiat said.

University of Queensland scientists are expected to release more details on today about a human trial for a Covid-19 vaccine that gives hope of a breakthrough in combating the virus. Director of the Institute for Translation Medicine and Biotechnology Vadim Tarasov has revealed that the first batch of volunteers will be discharged on July 15 and the second group will be discharged on July 20. The report said the vaccine was produced by the Gamalei Institute of Epidemiology and Microbiology and that its safety had been confirmed. Australia's medical regulator, the Therapeutic Goods Administration (TGA), explains this phase can test the potential cure for between 100 to 300 participants. Another is being developed by Imperial College London and its has entered the Phase II stage. "We worked with this vaccine, starting with preclinical studies and protocol development, and clinical trials are now underway", Tarasov noted.

He clarified, however, that it is not yet certain that any of the vaccine candidates now being worked on will yield results, because scientists do not know, he said, the level of immunity people will need to prevent infection. In Phase II, the clinical study is expanded and the vaccine is given to people who have characteristics (such as age and physical health) similar to those for whom the new vaccine is intended. Sinovac and Instituto Butantan are developing one which is at the Phase III stage.

Other reports by Click Lancashire

Discuss This Article